Product

Diltiazem HCl

Pharmaceutical Form

Capsules

Strengths

120 mg, 180 mg, 240 mg and 300 mg

Release Characteristics

Sustained Release (like Synthélabo’s – France – TILDIEM LP capsules)

Posology

Once daily

Raw Material

DMF available

Chemical Pharmaceutical Dossier

Available

Parmacokinetics

Multiple dose (steady state) two-way crossover bioequivalence study on 20 healthy volunteers vs. Synthélabo’s (France) TILDIEM LP, diltiazem HCl sustained release 300 mg capsules.

Registration underway

Morocco

Marketing

Egypt, Finland, Greece, United Kingdom.

Notes

Free Sale Certificate available